In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease
about
Interactions of metals and Apolipoprotein E in Alzheimer's diseaseCopper excess, zinc deficiency, and cognition loss in Alzheimer's diseaseMulti-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseCopper-2 Ingestion, Plus Increased Meat Eating Leading to Increased Copper Absorption, Are Major Factors Behind the Current Epidemic of Alzheimer's DiseaseIron chelation and multiple sclerosisStructure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasisIssues raised involving the copper hypotheses in the causation of Alzheimer's diseaseDivalent Copper as a Major Triggering Agent in Alzheimer's DiseaseIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesNanoscale biogenic iron oxides and neurodegenerative disease.Role of iron in neurodegenerative diseases.Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways.Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity.Role of metal ions in the cognitive decline of Down syndrome.Influence of water quality on cholesterol-induced tau pathology: preliminary data.Role of oxidative stress and antioxidants in neurodegenerative diseases.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Copper and iron in Alzheimer's disease: a systematic review and its dietary implications.Biological consequences of zinc deficiency in the pathomechanisms of selected diseases.Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases.Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective.Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis.Iron and mechanisms of neurotoxicityInvolvement of oxidative stress in Alzheimer disease.An update on using vitamin E in Alzheimer's disease.Cu(2+) affects amyloid-β (1-42) aggregation by increasing peptide-peptide binding forces.Is Alzheimer's disease a mitochondrial disorder?NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.The correlation of hippocampal T2-mapping with neuropsychology test in patients with Alzheimer's disease.Detection, identification and mapping of iron anomalies in brain tissue using X-ray absorption spectroscopyRole of metal dyshomeostasis in Alzheimer's disease.Iron in neurodegenerative disorders.Copper: toxicological relevance and mechanisms.Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress.Metal homeostasis in Alzheimer's disease.Therapeutic options in Alzheimer's disease.Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
P2860
Q21131068-D216227F-25C1-4B3A-9EF5-64D965A146B6Q22252920-2F4D6838-0788-41DD-9BAD-C3B2765B179AQ26744105-29B58629-4A50-4F4C-A5B3-1BBB1880CE4BQ26775017-D6C0A23E-91F6-4F3C-9309-6F39094213D6Q27001743-5B1B4878-31D4-4BB7-A0CE-223D31A4C8BEQ27640596-DA87920C-1FB0-4F7B-B01B-9F40891FFE0CQ28248217-957F99A4-D5DE-45C8-BD2D-E0BD5C1B4600Q28260134-6C063CD1-FF37-4D44-BA66-BF21DBEB06A6Q28388335-A601E0D2-4666-4C37-8F86-648F4DDFC7BBQ30651553-DF31E0F5-9E9E-4320-A2A1-33353F016D05Q31038817-8ECEC9E6-E9FF-430D-9999-2E48B1E165D4Q31047131-C29FD403-5D10-4FE7-BF97-167717C95BA5Q32134706-0DC5D7A1-CAF6-422C-A736-DE9F430A3AA2Q33697856-B37557F9-F0EE-4B15-BEC7-877E6911C5A9Q33792132-67F7379A-1F06-4E6E-B76A-70E85F4A534DQ33894668-F58BC5D8-7D60-4262-922C-C61F955924B1Q34154938-0275A6D5-47B2-4E7F-B349-E86ABB885A0FQ34193337-CAEEA607-78E6-4135-B4AD-7FB00B119183Q34201410-978ADC96-7986-43C8-B62F-E4A137C94700Q34243472-EEA97A37-4FC3-4868-9F3F-BEF94A75698EQ34243986-FB31DC98-04B1-4AA7-99B4-EC25EA1DD0BDQ34398474-2DDDA328-36D0-4065-A24C-EA3914F46BADQ34417983-DC093F20-D4D1-4BCC-8425-5913A048FE56Q34460764-72A38F70-F3BF-4F0D-A148-D3FF436ADF61Q34545547-DDDF0D29-917B-4649-B152-2B62AB08C8C5Q34616619-9E2D53D9-0B17-4713-A722-2FFA1B1C1656Q34639502-C2121228-CBF7-407C-BFB0-B819ACCAC97EQ34956340-3016EDE3-FCC7-42EC-A917-AADF5A900449Q34998995-A9059A67-F4BB-49A4-8C9C-A7F717FD3FF9Q35010262-703ED701-2897-49AB-8DE8-0D923AE1AB9DQ35051759-FCF059E8-3790-4165-A4DD-C7ED6F4A5006Q35051952-C0354855-F0F8-47F9-928C-371F904CF130Q35112542-3F3EE1B8-F4D3-4443-AD03-60C3C1C58F53Q35118976-5C6BF477-C04A-4CEA-8A1D-17495F293B33Q36330352-B2345026-171B-4837-B71C-368870604E7FQ36492356-DCDD3B4F-C23E-4B6C-B04C-41BDD8572129Q36511328-470D7978-1468-4393-B565-456E375FF941Q36817040-AB676C65-B764-44AC-AA65-205E2E01D6C3Q36872887-80C72AD1-2A59-4B30-A19E-43CE219C304EQ37005143-54E6589D-811A-4C22-8DBD-68D13440D27C
P2860
In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease
description
scientific article published on 01 January 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2001
@uk
name
In Situ Oxidative Catalysis by ...... Plaques in Alzheimer’s Disease
@en
In Situ Oxidative Catalysis by ...... Plaques in Alzheimer’s Disease
@nl
type
label
In Situ Oxidative Catalysis by ...... Plaques in Alzheimer’s Disease
@en
In Situ Oxidative Catalysis by ...... Plaques in Alzheimer’s Disease
@nl
prefLabel
In Situ Oxidative Catalysis by ...... Plaques in Alzheimer’s Disease
@en
In Situ Oxidative Catalysis by ...... Plaques in Alzheimer’s Disease
@nl
P2093
P1476
In situ oxidative catalysis by ...... le for bound transition metals
@en
P2093
P304
P356
10.1046/J.1471-4159.2000.0740270.X
P407
P50
P577
2000-01-01T00:00:00Z